SUZUKEN CO LTD
SUZUKEN CO LTD
Share · JP3398000004 · 914027 (XTKS)
Overview
No Price
Closing Price XTKS 31.10.2025: 5.815,00 JPY
31.10.2025 05:42
Current Prices from SUZUKEN CO LTD
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
9987.T
JPY
31.10.2025 05:42
5.815,00 JPY
21,00 JPY
+0,36 %
OTC: UTC
UTC
SZUKF
USD
30.10.2025 20:00
30,30 USD
0,00 USD
Share Float & Liquidity
Free Float 78,97 %
Shares Float 56,31 M
Shares Outstanding 71,31 M
Invested Funds

The following funds have invested in SUZUKEN CO LTD:

Fund
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in million
28,40
Percentage (%)
0,04 %
Fund
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in million
69,53
Percentage (%)
0,04 %
Company Profile for SUZUKEN CO LTD Share
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
Get up to date insights from finAgent about SUZUKEN CO LTD

Company Data

Name SUZUKEN CO LTD
Company Suzuken Co., Ltd.
Website https://www.suzuken.co.jp
Primary Exchange XTKS Tokyo
WKN 914027
ISIN JP3398000004
Asset Class Share
Sector Healthcare
Industry Medical - Distribution
CEO Shigeru Asano
Market Capitalization 418 Mrd.
Country Japan
Currency EUR
Employees 13,1 T
Address 8 Higashi Kataha-machi, 461-8701 Nagoya
IPO Date 2001-01-01

Ticker Symbols

Name Symbol
Over The Counter SZUKF
Tokyo 9987.T
More Shares
Investors who hold SUZUKEN CO LTD also have the following shares in their portfolio:
LENOVO GROUP 22/32 REGS
LENOVO GROUP 22/32 REGS Bond
TRIUMPH GOLD CORP.
TRIUMPH GOLD CORP. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025